Abstract | OBJECTIVE: DATA SOURCES: A MEDLINE search was conducted from 1996 to February 2003. Bibliographies of all articles were reviewed and pertinent articles were included. Abstracts from major meetings in 2002 and 2003 were also reviewed. STUDY SELECTION AND DATA EXTRACTION: All published studies were included in the review. DATA SYNTHESIS: CONCLUSIONS: No drug therapy exists to fully ameliorate or correct the cosmetic changes of HIV-associated lipodystrophy. Clinicians must weigh the benefits and risks of each agent and individualize treatment for each patient.
|
Authors | Sandra Benavides, Milap C Nahata |
Journal | The Annals of pharmacotherapy
(Ann Pharmacother)
Vol. 38
Issue 3
Pg. 448-57
(Mar 2004)
ISSN: 1060-0280 [Print] United States |
PMID | 14755064
(Publication Type: Journal Article, Review)
|
Chemical References |
- Hypoglycemic Agents
- Recombinant Proteins
- Thiazolidinediones
- Human Growth Hormone
- Metformin
|
Topics |
- Adipose Tissue
(drug effects, metabolism)
- Contraindications
- HIV-Associated Lipodystrophy Syndrome
(drug therapy)
- Human Growth Hormone
(adverse effects, therapeutic use)
- Humans
- Hypoglycemic Agents
(therapeutic use)
- Male
- Metformin
(therapeutic use)
- Randomized Controlled Trials as Topic
- Recombinant Proteins
(adverse effects, therapeutic use)
- Thiazolidinediones
(adverse effects, therapeutic use)
- Treatment Outcome
|